IMMUNE PRIVILEGE TO MHC‐DISPARATE TUMOR GRAFTS IN THE ANTERIOR CHAMBER OF THE EYE: I. QUANTITATIVE ANALYSIS OF INTRAOCULAR TUMOR GROWTH AND THE CORRESPONDING DELAYED HYPERSENSITIVITY RESPONSE

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Transplantation

• Publication date

  1989-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/00007890-198904000-00018PMID 2523103
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunogenetic basis for immunologic privilege in the anterior chamber of the eye

  2004cited by this paper
• Suppression of antigraft immunity by preimmunization. III. Characterization of suppressor T cells involved in suppression of the efferent phase of DTH against alloantigens.

  1986cited by this paper
• Histopathologic analysis of intraocular allogeneic tumors in mice.

  1985cited by this paper
• Suppression of antigraft immunity by preimmunization. IV. Persistence by long-lived recirculating suppressor T cells.

  1985cited by this paper
• Functional capacity of solid tissue transplants in the brain: evidence for immunological privilege

  1985cited by this paper
• Characterization of the suppressor cell(s) responsible for anterior chamber-associated immune deviation (ACAID) induced in BALB/c mice by P815 cells.

  1985cited by this paper
• SUPPRESSION OF ANTIGRAFT IMMUNITY BY PREIMMUNIZATION: II. Characterization of the Suppressor Cells

  1984cited by this paper
• Alloantigens placed into the anterior chamber of the eye induce specific suppression of delayed-type hypersensitivity but normal cytotoxic T lymphocyte and helper T lymphocyte responses.

  1983cited by this paper
• IMMUNE PRIVILEGE IN THE TESTIS

  1983cited by this paper
• ANALYSIS OF ANTIBODY PRODUCTION INDUCED BY ALLOGENEIC TUMOR CELLS INOCULATED INTO THE ANTERIOR CHAMBER OF THE EYE

  1982cited by this paper
• Deviant immune responses to allogeneic tumors injected intracamerally and subcutaneously in mice.

  1981cited by this paper
• SUPPRESSION OF ANTIGRAFT IMMUNITY BY PREIMMUNIZATION: I. KINETIC ASPECTS AND SPECIFICITY

  1981cited by this paper
• Systemic immune unresponsiveness induced in adult mice by anterior chamber presentation of minor histocompatibility antigens

  1980cited by this paper
• Surface densities of Langerhans cells in relation to rodent epidermal sites with special immunologic properties.

  1980cited by this paper
• Immunologically privileged sites.

  1977cited by this paper
• Subversion of host defense mechanisms by malignant tumors: an established tumor as a privileged site for bacterial growth

  1977cited by this paper
• Carcinogenesis in an immunologically privileged site.

  1975cited by this paper
• A RECONSIDERATION OF IMMUNOLOGICAL PRIVILEGE WITHIN THE ANTERIOR CHAMBER OF THE EYE

  1975cited by this paper
• Transplantation immunology of the anterior chamber of the eye. I. An intra-ocular graft-vs-host reaction (immunogenic anterior uveitis).

  1975cited by this paper
• THE LYMPHATIC STATUS OF HAMSTER CHEEK POUCH TISSUE IN RELATION TO ITS PROPERTIES AS A GRAFT AND AS A GRAFT SITE

  1971cited by this paper
• HETEROTRANSPLANTATION OF TUMORS

  1957cited by this paper
• The significance of the heterologous transplantability of human cancer

  1952cited by this paper
• Homologous and heterologous growth of transplants of various tissues during the course of development in the mouse

  1949cited by this paper
• FAMILIAL MAMMARY TUMORS IN THE RABBIT

  1940cited by this paper

• Recovery of activated cytotoxic T cells from minor H incompatible tumor graft rejection sites. 1989.

  2007cites this paper
• Fas ligand exerts its pro‐inflammatory effects via neutrophil recruitment but not activation

  2007cites this paper
• Termination of systemic immunity in the presence of intraocular tumors: influence of ocular immune privilege on tumor vaccines.

  2006cites this paper
• Termination of Systemic Immunity in the Presence of Intraocular Tumors: Influence of Ocular Immune Privilege on Tumor Vaccines

  2006cites this paper
• Ocular immune privilege and CTL tolerance

  2004cites this paper
• Retinal transplantation: progress and problems in clinical application

  2003cites this paper
• Cell transplantation as a treatment for retinal disease.

  2001cites this paper
• Immune privilege is extended, then withdrawn, from allogeneic tumor cell grafts placed in the subretinal space.

  1999cites this paper
• Immunotherapy of uveal melanoma.

  1999cites this paper
• IMMUNOTHERAPY AND GENE THERAPY OF UVEAL MELANOMA

  1999cites this paper
• Analysis of immune deviation elicited by antigens injected into the subretinal space.

  1998cites this paper
• Das Immunprivileg des Auges

  1998cites this paper
• [Immune privilege of the eye].

  1998cites this paper
• Imposing deviant immunity on the presensitized state.

  1994cites this paper
• Evidence that peritoneal exudate cells cultured with eye-derived fluids are the proximate antigen-presenting cells in immune deviation of the ocular type.

  1993cites this paper
• Complete elimination ('cure') of progressively growing intraocular tumors by local injection of tumor-specific CD8+ T lymphocytes.

  1993cites this paper
• Impaired cell-mediated immunity in mice bearing healthy orthotopic corneal allografts.

  1993cites this paper
• Anterior chamber-associated immune deviation elicited via primate eyes.

  1993cites this paper
• ORTHOTOPIC CORNEAL TRANSPLANTATION IN MICE—EVIDENCE THAT THE IMMUNOGENETIC RULES OF REJECTION DO NOT APPLY

  1992cites this paper
• Immunoregulatory mechanisms of the eye.

  1992cites this paper
• Local T helper cell signals by lymphocytes infiltrating intraocular tumors.

  1992cites this paper
• TERMINATION OF IMMUNE PRIVILEGE IN THE ANTERIOR CHAMBER OF THE EYE WHEN TUMOR‐INFILTRATING LYMPHOCYTES ACQUIRE CYTOLYTIC FUNCTION

  1991cites this paper
• Infiltration and accumulation of precursor cytotoxic T-cells increase with time in progressively growing ocular tumors.

  1991influential citation
• Failure of infiltrating precursor cytotoxic T cells to acquire direct cytotoxic function in immunologically privileged sites.

  1990cites this paper
• Aqueous humor factors and their effect on the immune response in the anterior chamber.

  1990cites this paper
• Recovery of Activated Cytotoxic T Cells from Minor H Incompatible Tumor Graft Rejection Sites

  1989cites this paper